Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to publicize a competition for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide outstanding environments for the training of new researchers capable of addressing high priority objectives in muscular dystrophy research. Center investigators are expected to participate in important community outreach efforts to increase awareness of their research activities in the patient and advocacy communities and to incorporate community perspectives into the conduct of patient-centered research.


  • Letter of Intent Due Date: 30 days prior to the application due date
  • Application Due Date(s): Sep. 30, 2022

RFA-AR-23-001 Expiration Date October 01, 2022

Agency Website



Amount Description

Applicants may request up to $1,000,000 direct costs/year (exclusive of facilities and administrative costs of subcontractors with collaborating organizations).

Applications may request up to five years of support. 

      Funding Type





      Curriculum Development
      Medical - Basic Science
      Medical - Clinical Science
      Medical - Translational

      External Deadline

      September 30, 2022